Bodaghi, Bahram
Nguyen, Quan Dong
Jaffe, Glenn
Khoramnia, Ramin
Pavesio, Carlos
Article History
Received: 14 July 2020
Accepted: 29 October 2020
First Online: 30 November 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: <b>BB:</b> AbbVie, Alimera, Allergan, Bayer, Horus Pharma, Novartis, Santen, Thea. <b>QDN:</b> Stanford University, the employer of QDN, has received research funding from various pharmaceutical institutions for the studies of uveitis and ocular inflammatory diseases. QDN serves on the Uveitis Scientific Advisory Boards for AbbVie, Alimera Sciences, Bausch and Lomb, EyePoint, and Santen. <b>GJ:</b> Consultant - AbbVie, Inc., Alcon Laboratories,Novartis Pharma AG, Neurotech USA, Inc., Heidelberg Engineering, EyePoint Pharmaceuticals, EYEVENSYS. <b>KR</b>: has received lecture fees and travel grants from Allergan and Alimera. <b>CP:</b> Consultant - Allergan, Alimera Sciences, EYEVENSYS, Servier Laboratories, Santen Pharmaceutical Co., Ltd., AbbVie, Inc.